Cargando…

Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels

Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Yoshimi, Hayama, Kohei, Sakakihara, Shouichi, Nishino, Kunihiko, Noji, Hiroyuki, Iino, Ryota, Yamaguchi, Akihito
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075257/
https://www.ncbi.nlm.nih.gov/pubmed/21533264
http://dx.doi.org/10.1371/journal.pone.0018547
_version_ 1782201760296730624
author Matsumoto, Yoshimi
Hayama, Kohei
Sakakihara, Shouichi
Nishino, Kunihiko
Noji, Hiroyuki
Iino, Ryota
Yamaguchi, Akihito
author_facet Matsumoto, Yoshimi
Hayama, Kohei
Sakakihara, Shouichi
Nishino, Kunihiko
Noji, Hiroyuki
Iino, Ryota
Yamaguchi, Akihito
author_sort Matsumoto, Yoshimi
collection PubMed
description Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, ΔacrB (ΔB), ΔtolC (ΔC) and ΔacrBΔtolC (ΔBC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-β-naphthylamide (PAβN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, ΔB or ΔC easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in ΔB. Consequently, fluorescent medium in ΔB and fluorescent cells of ΔC and ΔBC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in ΔBC/pABM but not in ΔBC/pXYM. PAβN increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in ΔC. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (ΔBC/pABM), and PAβN acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PAβN were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAβN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli.
format Text
id pubmed-3075257
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30752572011-04-29 Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels Matsumoto, Yoshimi Hayama, Kohei Sakakihara, Shouichi Nishino, Kunihiko Noji, Hiroyuki Iino, Ryota Yamaguchi, Akihito PLoS One Research Article Fluorescein-di-β-d-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by β-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, ΔacrB (ΔB), ΔtolC (ΔC) and ΔacrBΔtolC (ΔBC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-β-naphthylamide (PAβN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, ΔB or ΔC easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in ΔB. Consequently, fluorescent medium in ΔB and fluorescent cells of ΔC and ΔBC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in ΔBC/pABM but not in ΔBC/pXYM. PAβN increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in ΔC. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (ΔBC/pABM), and PAβN acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PAβN were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAβN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli. Public Library of Science 2011-04-12 /pmc/articles/PMC3075257/ /pubmed/21533264 http://dx.doi.org/10.1371/journal.pone.0018547 Text en Matsumoto et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Matsumoto, Yoshimi
Hayama, Kohei
Sakakihara, Shouichi
Nishino, Kunihiko
Noji, Hiroyuki
Iino, Ryota
Yamaguchi, Akihito
Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
title Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
title_full Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
title_fullStr Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
title_full_unstemmed Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
title_short Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels
title_sort evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3075257/
https://www.ncbi.nlm.nih.gov/pubmed/21533264
http://dx.doi.org/10.1371/journal.pone.0018547
work_keys_str_mv AT matsumotoyoshimi evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels
AT hayamakohei evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels
AT sakakiharashouichi evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels
AT nishinokunihiko evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels
AT nojihiroyuki evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels
AT iinoryota evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels
AT yamaguchiakihito evaluationofmultidrugeffluxpumpinhibitorsbyanewmethodusingmicrofluidicchannels